Login

Dr. Xiaoke (Ken) Liu, Cardiologist 00:00:00

Share On Facebook Share On Twitter

Athletes & Heart Health: Ask Mayo Clinic Health System

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
investments in enterprise cloud and smart data companies|Miriam Rivera,Co-Founder, and Managing Director,Ulu Ventures
00:10:00
Datasonic is ready to help the government create a special subsidy card equipped with a technological system to support the targeted subsidy mechanism | JENS MONTANANA, CEO, Datasonic Group BhdDSONIC:KLS
00:00:00
Destiny Pharma's nasal spray project already delivering - Neil Clark, CEO, Destiny Pharma
00:10:00
committed to maintaining the highest legal and ethical standards in conducting its business|Ryan Tolkin,CEO,Schonfeld Securities LLC
00:10:00
Central Asia Metals: Overview of Operations and Recent Acquisitions
00:10:00
URA Holdings' Strategy to Shift Valuation Through Gravelotte Production | Dr. Bernard Olivier ,CEO ,URA Holdings Plc.
00:10:00
no one could change the rules on you|Yoko Hongyu Li,Partner,Andreessen Horowitz
00:10:00
Belive it or not techonology can save time to make any decesions|Chris Wake,Founder, Atypical Ventures
00:10:00
Dambisa Moyo on Why Foreign Aid Fails Africa|Dambisa Moyo
00:10:00
Why I Specialize in Working with Attorneys
00:10:00
Galena Mining: Advancing the Abra Base Metals Project in Western Australia
00:10:00
Reverse Pitch: Hearing from the Investors|Amanda Schutzbank,Co-Founder & General Partner,Willow Growth Partners

© 2026 Nehu